Vitro Biopharma, Inc. reported earnings results for the second quarter and six months ended April 30, 2023. For the second quarter, the company reported revenue was USD 0.307843 million compared to USD 1.05 million a year ago. Net loss was USD 1.41 million compared to USD 1.34 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.52 a year ago.
For the six months, revenue was USD 0.651874 million compared to USD 2.21 million a year ago. Net loss was USD 2.6 million compared to USD 1.7 million a year ago. Basic loss per share from continuing operations was USD 0.52 compared to USD 0.78 a year ago.